Anti-fibrotic and anti-inflammatory activity of the adenosine receptor 2b antagonist, GS-6201, in a murine model of PSC

被引：0
|
作者：
Karnik, Satyajit [1 ]
Kim, Yong Ook [2 ]
Nash, Michelle [1 ]
Sulfab, Maisoun [1 ]
Zeng, Dewan [3 ]
Zhong, Hongyan [1 ]
Robson, Simon C. [4 ]
Schuppan, Detlef [2 ,4 ]
Tumas, Daniel [1 ]
机构：
[1] Gilead Sci, Biol, Foster City, CA USA
[2] Johannes Gutenberg Univ Mainz, Inst Translat Immunol, D-55122 Mainz, Germany
[3] Gilead Sci, Clin Res, Foster City, CA USA
[4] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
779
引用
收藏
页码：576A / 577A
页数：2
相关论文
共 50 条
  • [41] An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
    Nishimoto, Tetsuya
    Mlakar, Logan
    Takihara, Takahisa
    Feghali-Bostwick, Carol
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 28 (02) : 1102 - 1105
  • [42] The anti-inflammatory and cardioprotective properties of A2A adenosine receptor agonists
    Glover, David
    Patel, Rajan
    Broisat, Alexis
    Kabul, Hasan
    Ruiz, Mirta
    Goodman, Craig
    Kramer, Christopher
    Linden, Joel
    Beller, George
    PURINERGIC SIGNALLING, 2008, 4 : S95 - S95
  • [43] Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity
    D'Amico, Derin C.
    Aya, Toshi
    Human, Jason
    Fotsch, Christopher
    Chen, Jian Jeffrey
    Biswas, Kaustav
    Riahi, Bobby
    Norman, Mark H.
    Willoughby, Christopher A.
    Hungate, Randall
    Reider, Paul J.
    Biddlecome, Gloria
    Lester-Zeiner, Dianna
    Van Staden, Carlo
    Johnson, Eileen
    Kamassah, Augustus
    Arik, Leyla
    Wang, Judy
    Viswanadhan, Vellarkad N.
    Groneberg, Robert D.
    Zhan, James
    Suzuki, Hideo
    Toro, Andras
    Mareska, David A.
    Clarke, David E.
    Harvey, Darren M.
    Burgess, Laurence E.
    Laird, Ellen R.
    Askew, Benny
    Ng, Gordon
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 607 - 610
  • [44] Attenuation of Armanni-Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011
    Lau, X.
    Zhang, Y.
    Kelly, D. J.
    Stapleton, D. I.
    DIABETOLOGIA, 2013, 56 (03) : 675 - 679
  • [45] Activated Primary Human Lung Fibroblasts Produce Anti-Inflammatory And Anti-Fibrotic Peroxisome Proliferator-Activated Receptor Gamma (pparγ) Ligands
    Lacy, S. H.
    Woeller, C. F.
    Thatcher, T. H.
    Sime, P. J.
    Phipps, R. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [46] Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
    Antar, Samar A.
    Saleh, Mohamed A.
    Al-Karmalawy, Ahmed A.
    LIFE SCIENCES, 2022, 309
  • [47] Anti-inflammatory Properties of Murine Mesenchymal Stem Cells: Role of Interleukin 1 Receptor Antagonist
    Pandey, Amitabh C.
    Dutreil, Maria F.
    Phinney, Donald G.
    FASEB JOURNAL, 2008, 22
  • [48] Anti-inflammatory and anti-fibrotic effects of intravenous adiposederived stem cell transplantation in a mouse model of bleomycininduced interstitial pneumonia (vol 7, 2017)
    Kotani, Takuya
    Masutani, Ryota
    Suzuka, Takayasu
    Oda, Katsuhiro
    Makino, Shigeki
    Ii, Masaaki
    SCIENTIFIC REPORTS, 2018, 8
  • [49] Oral anti-inflammatory action of NPC 18884, a novel bradykinin B2 receptor antagonist
    Saleh, TSF
    Vianna, RMJ
    Creczynski-Pasa, TB
    Chakravarty, S
    Mavunkel, BJ
    Kyle, DJ
    Calixto, JB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 363 (2-3) : 179 - 187
  • [50] ANTI-INFLAMMATORY AND ANTI-FIBROTIC EFFECTS OF INTRAVENOUS ADIPOSE-DERIVED STEM CELL TRANSPLANTATION IN A MOUSE MODEL OF BLEOMYCIN-INDUCED SCLERODERMA
    Suzuka, Takayasu
    Kotani, Takuya
    Matsuda, Shogo
    Masaaki, I. I.
    Takeuchi, Tohru
    Arawaka, Shigeki
    Nagai, Koji
    Wada, Yumiko
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 456 - 457
12345